Metraipolis › archive › dc_13d4e06b1d3d

An organolutetium nanosensitizer synergizes with PARP inhibition to unleash STING-mediated immunity for low-dose radioimmunotherapy — Europe PMC PMID:41356181

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41356181
DOI
10.7150/thno.124034
License (as archived)
solo-consultazione
Archived
2026-11-07T04:40:27.349Z
SHA-256 of the archived text
63ebbe184f401e21898aa632bd75f2f9c54f6e55973da5f515370b15ccc3e4c1
Stable URL of this page
https://metraipolis.com/documento/dc_13d4e06b1d3d

How to cite

An organolutetium nanosensitizer synergizes with PARP inhibition to unleash STING-mediated immunity for low-dose radioimmunotherapy — Europe PMC PMID:41356181 — Europe PMC (en), https://europepmc.org/article/MED/41356181 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_13d4e06b1d3d (Metraipolis archive dc_13d4e06b1d3d, sha256 63ebbe184f401e21898aa632bd75f2f9c54f6e55973da5f515370b15ccc3e4c1)
BibTeX
@misc{dc13d4e06b1d3d,
  title = {An organolutetium nanosensitizer synergizes with PARP inhibition to unleash STING-mediated immunity for low-dose radioimmunotherapy — Europe PMC PMID:41356181},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41356181},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_13d4e06b1d3d; sha256 63ebbe184f401e21898aa632bd75f2f9c54f6e55973da5f515370b15ccc3e4c1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41356181. Agents can read the archived copy with the MCP tool read_document.